Business
ImprimisRx® Announces Supply Agreement with iOR Partners
ImprimisRx will supply iOR with a series of unique formulations needed during outpatient surgery SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the
About this update from Harrow, Inc.
[{"type":"text","content":"ImprimisRx will supply iOR with a series of unique formulations needed during outpatient surgery\nSAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of Harrow Health, Inc. (NASDAQ: HROW), announced that it has agreed to a product supply agreement with iOR Partners. Under the agreement, ImprimisRx will provide a variety of formulations needed for in-office surgeries, including the MKO Melt® and various injectable and topical products. iOR Partners is an innovator in the field of office-based cataract surgery, which is a surgical or invasive procedure performed by a licensed physician in a location other than a hospital or ambulatory surgery center that utilizes minimal to moderate anesthetics. By keeping their clinic and surgery center in one place, doctors can see more patients, employ the same staff for clinic and surgery, improve productivity, and lower patient anxiety by having procedures performed in a familiar environment. iOR is growing rapidly, expecting to have 75 office-based cataract surgery suites by the end of next year, accounting for more than 45,000 surgical procedures annually.\n John Saharek, President of ImprimisRx, commented, “iOR Partners has an exciting business model and we are thrilled to partner with them as they help ophthalmologists make it easier to provide high-quality care to their patients. In-office surgery is likely where the ophthalmic surgery market is headed, so we’re pleased to provide iOR with the pharmaceutical formulations needed to continue the impressive progress they’re making as they help lead our industry forward.” Tony Burns, Founder and Partner of iOR Partners, stated, “ImprimisRx is a trusted provider within the ophthalmic community offering a unique suite of formulations not available commercially, and are a natural fit for ophthalmologists looking to provide a more personalized and comfortable patient experience. Both companies are passionate about helping doctors to improve the patient experience, so we are excited to have ImprimisRx working with us going forward.” About iOR Partners iOR Partners is the only company dedicated to office-based cataract surgery suites and has established more than 100 of them. iOR primarily develops Class A and C...